Olmesartan Medoxomil Tablet
Product Images NDC 33342-178

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil (NDC 33342-178). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Olmesartan Medoxomil Structure (Str)

Chemical structure of olmesartan medoxomil, showing its molecular arrangement with specific functional groups and ring structures characteristic of this antihypertensive agent.*

FDA Label Image

Figure (Olmesartan Medoxomil Figure)

A dose-response chart illustrating the placebo-adjusted reduction in blood pressure (mmHg) with varying doses of Olmesartan Medoxomil in mg. The graph shows two lines representing systolic and diastolic blood pressure reductions, with systolic BP reduction higher across doses compared to diastolic BP.*

FDA Label Image

125 (Olmesartan Medoxomil 5mg 30s)

Label for Olmesartan Medoxomil Tablets, USP 5 mg, in a package of 30 tablets. The label shows manufacturer as Macleods Pharma USA, Inc., Princeton, NJ. It includes storage instructions and a note to see the package insert for full prescribing information. Strength is displayed prominently as 5 mg in an orange box.*

FDA Label Image

125 (Olmesartan Medoxomil 5mg 90s)

Label for Olmesartan Medoxomil Tablets, USP, 5 mg, oral tablets. The label shows the dosage strength 5 mg prominently, with 90 tablets per container. The product is manufactured for Macleods Pharma USA, Inc., Princeton, NJ, and by Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India. The label includes storage instructions and a barcode.*

FDA Label Image

125 (Olmesartan Medoxomil 20mg 30s)

Label for Olmesartan Medoxomil Tablets USP 20 mg oral tablets from Macleods Pharmaceuticals Limited. The label shows the active ingredient strength as 20 mg, the package count as 30 tablets, and indicates it is Rx only. Storage instructions recommend 20° to 25°C, with excursions allowed between 15° to 30°C. The product is manufactured for Macleods Pharma USA, Inc. in Princeton, NJ, and by Macleods Pharmaceuticals Ltd. in Baddi, India. Barcodes and lot information areas are present.*

FDA Label Image

125 (Olmesartan Medoxomil 20mg 90s)

Olmesartan Medoxomil Tablets, USP 20 mg oral tablets packaging label. The label states the active ingredient as Olmesartan medoxomil, USP 20 mg per tablet. The package contains 90 tablets and is manufactured for Macleods Pharma USA, Inc., Princeton, NJ. Storage instructions recommend 20° to 25°C with excursions permitted to 15° to 30°C. The manufacturer is Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India.*

FDA Label Image

125 (Olmesartan Medoxomil 40mg 30s)

Label for Olmesartan Medoxomil Tablets, USP 40 mg, oral tablets supplied in a package of 30 tablets. The label indicates storage instructions and usual dosage note, with manufacturer listed as Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. The label also includes barcodes and regulatory information.*

FDA Label Image

125 (Olmesartan Medoxomil 40mg 90s)

Label for Olmesartan Medoxomil Tablets, USP 40 mg, oral tablets with a quantity of 90 tablets. The label shows the manufacturer as Macleods Pharmaceuticals Limited, Baddi, Himachal Pradesh, India, and Macleods Pharma USA, Inc., Princeton, NJ. Storage instructions and general dosage note are included. The label features barcodes and product identification details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.